These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 7248984)
1. Venous thrombosis during multimodal treatment of primary breast carcinoma. Weiss RB; Tormey DC; Holland JF; Weinberg VE Cancer Treat Rep; 1981; 65(7-8):677-9. PubMed ID: 7248984 [TBL] [Abstract][Full Text] [Related]
2. [Does primary tumor affect the prognosis in postmastectomy locoregional recurrence in breast carcinoma?]. Willner J; Kiricuta IC; Kölbl O Strahlenther Onkol; 1995 Jan; 171(1):18-28. PubMed ID: 7839301 [TBL] [Abstract][Full Text] [Related]
3. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L; J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260 [TBL] [Abstract][Full Text] [Related]
4. [Simultaneous radiochemotherapy in locoregional recurrent breast carcinoma after mastectomy. Results in patients with macroscopic residual tumor R2]. Renner H; van Kampen M Strahlenther Onkol; 1994 Aug; 170(8):441-52. PubMed ID: 8085210 [TBL] [Abstract][Full Text] [Related]
5. Isolate local failure after breast-conserving treatment for early breast cancer, about 57 cases. Deniaud-Alexandre E; Lauratet B; Lefranc JP; Genestié C; Lerouge D; Moureau-Zabotto L; Touboul E Cancer Radiother; 2004 Apr; 8(2):95-107. PubMed ID: 15063877 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome after postmastectomy radiation therapy for breast cancer patients at high risk for local-regional recurrence. Metz JM; Schultz DJ; Fox K; Glick J; Solin LJ Cancer J Sci Am; 1999; 5(2):77-83. PubMed ID: 10198729 [TBL] [Abstract][Full Text] [Related]
7. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution. Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400 [TBL] [Abstract][Full Text] [Related]
8. Breast cancer recurrences in elderly patients after lumpectomy. Shah S; Doyle K; Lange EM; Shen P; Pennell T; Ferree C; Levine EA; Perrier ND Am Surg; 2002 Aug; 68(8):735-9. PubMed ID: 12206612 [TBL] [Abstract][Full Text] [Related]
9. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence]. Fodor J Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868 [TBL] [Abstract][Full Text] [Related]
10. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma. Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156 [TBL] [Abstract][Full Text] [Related]
13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
14. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182 [TBL] [Abstract][Full Text] [Related]
15. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients]. Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583 [TBL] [Abstract][Full Text] [Related]
16. Breast conservation in patients with multiple ipsilateral synchronous cancers. Kaplan J; Giron G; Tartter PI; Bleiweiss IJ; Estabrook A; Smith SR J Am Coll Surg; 2003 Nov; 197(5):726-9. PubMed ID: 14585405 [TBL] [Abstract][Full Text] [Related]
17. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast. Holland JF; Glidewell O; Cooper RG Surg Gynecol Obstet; 1980 Jun; 150(6):817-21. PubMed ID: 7376042 [TBL] [Abstract][Full Text] [Related]
18. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514 [TBL] [Abstract][Full Text] [Related]
19. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044 [TBL] [Abstract][Full Text] [Related]
20. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. van der Sangen MJ; van de Poll-Franse LV; Roumen RM; Rutten HJ; Coebergh JW; Vreugdenhil G; Voogd AC Eur J Surg Oncol; 2006 Feb; 32(1):34-8. PubMed ID: 16305821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]